课题基金 / 基金详情

OPIOIDS AND HORMONAL METABOLIC ABNORMALITIES IN POLYCYSTIC OVARIAN DISEASE (HUMAN

OPIOIDS AND HORMONAL METABOLIC ABNORMALITIES IN POLYCYSTIC OVARIAN DISEASE (HUMAN
阿片类药物与多囊卵巢病（人类）中的激素代谢异常
批准号：
3926854
负责人：
FOUAD R KANDEEL
金额：
$0.0万
依托单位：
LOS ANGELES COUNTY HARBOR-UCLA MED CTR
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3926854
关键词：
endorphins gonadotropin releasing factor human subject human therapy evaluation metabolism disorder naloxone polycystic ovary syndrome progesterone weight control

项目摘要

项目成果

FOUAD R KANDEEL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Whether endogenous opioid is a major mechanism for metabolic abnormalities seen in polycystic ovarian disease will be studied. Hormonal and metabolic responses in patients with PCOD will be studied before and after anti-narcotic, anti-opioid treatment. These changes will be compared to those seen in patients treated with weight reduction diets.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Biology
CLINICAL TRIAL: ISLET TRANSPLANTATION ALONE (ITA) IN PATIENTS WITH DIFFICULT TO
CLINICAL TRIAL: ISLET TRANSPLANTATION ALONE (ITA) IN PATIENTS WITH DIFFICULT TO
2006 Rachmiel Levine Symposium - Advances in Diabetes Research: From Cell Biology
海外基金